IMMX
NASDAQ · Biotechnology
Immix Biopharma Inc
$8.32
-0.23 (-2.69%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+44.0% upside
Low Target
$7.05
Average Target
$11.98
High Target
$14.20
Current Price
$8.32
Current
$8.32
$8.32
Target
$11.98
$11.98
$7.05
$11.98 avg
$14.20
Scenario Analysis
Bear Case
$7.05
-15.3%
Low target
Base Case
$11.98
+44.0%
Avg target
Bull Case
$14.20
+70.7%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$12.14
-31.5% from high
52-Week Low
$1.94
+328.9% from low
Target vs 52W High
$11.98
-1.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |